This work is licensed under the Creative Commons Attribution 4.0 International License.
Jun Y, Jimmy S, Peter JF. Diagnosing endocrine hypertension: a practical approach. Nephrol 2017;22(9):663–677.JunYJimmySPeterJFDiagnosing endocrine hypertension: a practical approachNephrol201722966367710.1111/nep.1307828556585Search in Google Scholar
Isabella S, Felix B, Thomas FL. Secondary causes of hypertension. In: Camm AJ, Lüscher TF, Maurer G, Serruys PW, editors. ESC CardioMed. 3rd ed. London: Oxford University Press; 2018;IsabellaSFelixBThomasFLSecondary causes of hypertensionIn:CammAJLüscherTFMaurerGSerruysPWeditors.ESC CardioMed3rd ed.LondonOxford University Press2018Search in Google Scholar
Reena MT, Ewa R, Prapimporn CS, Leonor C, Endocrine hypertension: An overview on the current etiopathogenesis and management options. World J Hypertens 2015;5(2):14–27.ReenaMTEwaRPrapimpornCSLeonorCEndocrine hypertension: An overview on the current etiopathogenesis and management optionsWorld J Hypertens201552142710.5494/wjh.v5.i2.14458278926413481Search in Google Scholar
William FY, David AC, Jacques WML, Michael S, Stephen CT. Screening for endocrine hypertension: an endocrine society scientific statement. Endocr Rev 2017;38(2):103–22.WilliamFYDavidACJacquesWMLMichaelSStephenCTScreening for endocrine hypertension: an endocrine society scientific statementEndocr Rev20173821032210.1210/er.2017-00054Search in Google Scholar
Er LK, Wu VC. Call for screening for primary aldosteronism: an underdiagnosed and treatable disease, J Thorac Dis 2018;10(2):557–9.ErLKWuVCCall for screening for primary aldosteronism: an underdiagnosed and treatable diseaseJ Thorac Dis2018102557910.21037/jtd.2018.01.71586468929607111Search in Google Scholar
Monticone S, Burrello J, Tizzani D, Bertello C, Viola A, Buffallo F, et.al. Prevalence and clinical manifestations of primary aldosteronism encountered in primary care practice. J Am Coll Cardiol 2017;69(14):1811–20.MonticoneSBurrelloJTizzaniDBertelloCViolaABuffalloFPrevalence and clinical manifestations of primary aldosteronism encountered in primary care practiceJ Am Coll Cardiol2017691418112010.1016/j.jacc.2017.01.05228385310Search in Google Scholar
Born-Frontsberg E, Reincke M, Rump LC, Lorenz R, Hahner S, Diederich S. Cardiovascular and cerebrovascular comorbidities of hypokalemic and normokalemic primary aldosteronism: results of the German Conn's Registry. J Clin Endocrinol Metabol 2009;94(4):1125–30.Born-FrontsbergEReinckeMRumpLCLorenzRHahnerSDiederichSCardiovascular and cerebrovascular comorbidities of hypokalemic and normokalemic primary aldosteronism: results of the German Conn's RegistryJ Clin Endocrinol Metabol200994411253010.1210/jc.2008-211619190103Search in Google Scholar
Funder JW, Carey RM, Mantero F, Murad MH, Reincke M, Shibata H, et.al. The management of primary aldosteronism: case detection, diagnosis, and treatment: An Endocrine Society clinical practice guideline. J Clin Endocrinol Metabol 2016;101(5):L1889–916.FunderJWCareyRMManteroFMuradMHReinckeMShibataHThe management of primary aldosteronism: case detection, diagnosis, and treatment: An Endocrine Society clinical practice guidelineJ Clin Endocrinol Metabol20161015L188991610.1210/jc.2015-406126934393Search in Google Scholar
Zhou Y, Zhang M, Ke S, Liu L. Hypertension outcomes of adrenalectomy in patients with primary aldosteronism: a systematic review and meta-analysis. BMC Endocr Disord 2017;17(1):61.ZhouYZhangMKeSLiuLHypertension outcomes of adrenalectomy in patients with primary aldosteronism: a systematic review and meta-analysisBMC Endocr Disord20171716110.1186/s12902-017-0209-z562739928974210Search in Google Scholar
Kounatiadis P, Petroglou D, Kolettas V, Karvounis H, Primary aldosteronism of late onset: a case report. HIPPOKRATIA 2014;18(2):180–82.KounatiadisPPetroglouDKolettasVKarvounisHPrimary aldosteronism of late onset: a case reportHIPPOKRATIA201418218082Search in Google Scholar
Yu R, Furmark L, Wong C, Cardiac abnormalities associated with pheochromocytoma and other adrenal tumors. Endocr Pract 2009;15(1):10–16.YuRFurmarkLWongCCardiac abnormalities associated with pheochromocytoma and other adrenal tumorsEndocr Pract2009151101610.4158/EP.15.1.1019211391Search in Google Scholar
Tsirilin A, Oo Y, Sharma R, Kansara A, Gliwa A, Banerji MA, Pheochromocytoma: a review. Maturitas 2014;77(3):229–38.TsirilinAOoYSharmaRKansaraAGliwaABanerjiMAPheochromocytoma: a reviewMaturitas20147732293810.1016/j.maturitas.2013.12.00924472290Search in Google Scholar
Guerrero MA, Schreinermakers JM, Vriens MR, et al. Clinical spectrum of pheochromocytoma. J Am Coll Surg 2009;209(6):727.GuerreroMASchreinermakersJMVriensMRClinical spectrum of pheochromocytomaJ Am Coll Surg2009209672710.1016/j.jamcollsurg.2009.09.02219959041Search in Google Scholar
Kassim TA, Clarke DD, Mai VQ, et al. Catecholamine-induced cardiomyopathy. Endocr Pract 2008;14(9):1137–49.KassimTAClarkeDDMaiVQCatecholamine-induced cardiomyopathyEndocr Pract200814911374910.4158/EP.14.9.113719158054Search in Google Scholar
Chioncel V, Adam F, Sinescu I, Păun D, Sinescu C. Particularitățile clinice și paraclinice la pacienții hipertensivi cu feocromocitom – studiu retrospectiv. Rom J Cardiol 2012:22(2).ChioncelVAdamFSinescuIPăunDSinescuCParticularitățile clinice și paraclinice la pacienții hipertensivi cu feocromocitom – studiu retrospectivRom J Cardiol2012222Search in Google Scholar
Radojkovic D, Stojanovic M, Pesic M, Radojkovic M, Radenkovic S, et al. Clinically “silent” giant pheochromocytoma. case report. Acta Endocrinologica (BUC) 2013;9(1):121–29.RadojkovicDStojanovicMPesicMRadojkovicMRadenkovicSClinically “silent” giant pheochromocytomacase report. Acta Endocrinologica (BUC)2013911212910.4183/aeb.2013.121Search in Google Scholar
Skov J, Sundstrom A, Ludvigsson JF, Kampe O, Bensing S. Sex-specific risk of cardiovascular disease in autoimmune addison disease – a population-based cohort study. J Clin Endocrinol Metab 2019;104(6):2031–40.SkovJSundstromALudvigssonJFKampeOBensingSSex-specific risk of cardiovascular disease in autoimmune addison disease – a population-based cohort studyJ Clin Endocrinol Metab2019104620314010.1210/jc.2018-02298646922630608542Search in Google Scholar
Rahvar AH, Haas CS, Danneberg S, Harbeck B. Increased cardiovascular risk in patients with adrenal insufficiency: a short review. Biomed Res Int 2017;2017:3691913.RahvarAHHaasCSDannebergSHarbeckBIncreased cardiovascular risk in patients with adrenal insufficiency: a short reviewBiomed Res Int20172017369191310.1155/2017/3691913574244629376070Search in Google Scholar
Schumacher MM, Larsen TR, Sane DC. Cardiac manifestations of adrenal insufficiency. Rev Cardiovasc Med. 2016;17(3–4):131–36.SchumacherMMLarsenTRSaneDCCardiac manifestations of adrenal insufficiencyRev Cardiovasc Med.2016173–41313610.3909/ricm082028144020Search in Google Scholar
Henry M, Kevin GFT, Ian LR, Sleep, cognition and cortisol in Addison's disease: a mechanistic relationship. Front Endocrinol (Lausanne) 2021;12:694046.HenryMKevinGFTIanLRSleep, cognition and cortisol in Addison's disease: a mechanistic relationshipFront Endocrinol (Lausanne)20211269404610.3389/fendo.2021.694046842990534512546Search in Google Scholar